期刊文献+

抑胶素对大鼠脑胶质瘤细胞血管内皮生长因子作用的体内试验

Effect of antigliomatin on VEGF expression of the rat brain glioma
下载PDF
导出
摘要 目的研究抑胶素对大鼠脑胶质瘤血管内皮生长因子(VEGF)的影响。方法采用脑立体定向术,在Wistar大鼠脑尾状核接种C6细胞,应用免疫组织化学方法检测应用抑胶素前后对鼠脑胶质瘤血管内皮生长因子的影响。结果经抑胶素治疗后可见肿瘤内血管内皮生长因子阳性细胞密度下降,随浓度增加阳性率呈下降趋势。实验组(抑胶素浓度32μg/kg)较对照组表达降低(P<0.05);实验组(抑胶素浓度64μg/kg)与对照组比较有显著性差异(P<0.01);而实验组、(抑胶素浓度分别为8μg/kg及16μg/kg)与对照组相比较,无统计学意义;而顺铂组瘤体内VEGF与实验组比较无显著性差异(P>0.05)。结论抑胶素对肿瘤细胞的抑制作用可能通过血管内皮生长因子而起作用,但这种抑制作用与抑胶素本身的浓度有关,高浓度抑胶素抑制作用强。 Objective To study the effect of antigliomatin on the expression of vascular endothelial growth factor (VEGF). Methods C6 glioma cells were injected into the caudate nucleus of rats stereotaxically. Treat the rats with Antigliomatin for 7d. The VEGF expression was detected by immunohistochemical methods before and after the drug treatment. Results Compared with the control group,the number of VEGF-positive cells was decreased,which was inversely correlated with the drug concentration. In the third experimental group(drug concentration: 32μg/kg),the positive VEGF cell number was lower than that in control group (P〈0.05). In the forth experimental group (drug concentration:64μg/kg),the positive VEGF cell number was much less (P〈0.01). There are no significance in VEGF positive cell numbers between the experimental groups (drug concentrations:8μg/kg, 16μg/kg respectively) and the control group. In the treatment group with cisplatin,the VEGF-positive cell number was decreased,just like that in the forth experimental group(P〉0.05). Conclusion It suggests that the inhibitive effect of antigliomatin on the growth of rat brain glioma is probably via down-regulating the VEGF expression. This kind of regulation is positively correlated with the drug concentration.
出处 《中风与神经疾病杂志》 CAS CSCD 北大核心 2006年第4期413-415,共3页 Journal of Apoplexy and Nervous Diseases
基金 2003年吉林省卫生厅医学科研基金(2003-0323)
关键词 抑胶素 脑胶质瘤 血管内皮生长因子 Antigliomatin Brain glioma VEGF
  • 相关文献

参考文献10

  • 1王伟民.脑胶质瘤临床治疗现状与展望[J].中华神经医学杂志,2002,1(1):8-10. 被引量:6
  • 2张守涛,郭霭光,肖乐义,董建军,赵天增,薛歧庚,孔天翰,郭唯.东亚钳蝎神经毒素基因BmKCT的克隆与表达[J].西北农林科技大学学报(自然科学版),2002,30(6):30-33. 被引量:2
  • 3Barker M,Hoshine T,Gurcay O,et al.Development of an animal brain tumor model and its response to therapy with 1,3-Bis (2-chloroethy)nitrosourea[J].Cancer Res,1973,33:976-986.
  • 4nger D,Fuita T,Kishmoto S,et al.Inhibitory and suppress tumor growth[J].Nature,1990,348 (6301):555-557.
  • 5okry J,Nem ecek S,Adler J.et al.In culation of C6 cell suspension into the brain of adultrats:immunohis to chemical study[J].Funct Dev Morphol,1993,3 (3):175-177.
  • 6Senger DR,vander Water L,Brown LF,et al.Vasculer permeability factor (VPF,VEGF) in tumor biology[J].Cancer Metastasis Rev,1993,12 (3):303-324.
  • 7Connolly DT,Heuvelman DM,Nelson R,et al.Tumor vasculer permeability factor stimulates endothelial cell growth and angiogenesis[J].J Clin Invest,1989,84(5):1470-1478.
  • 8Valter MM,Hugel A,Huang HJ,et al.Expression of the Ets 1 transcription factoring human as trocytomasis associated with Fms like tyrosinekinase 1 (Flt 1)/vascular endothelial growth factor receptor 1 synthesis and neoangiogenesis[J].Cancer Res,1999,59(21):5608-5614.
  • 9李志强,袁先厚,文志华.VEGF与脑胶质瘤血管形成及预后意义的初步研究[J].中国临床神经外科杂志,2001,6(1):30-31. 被引量:4
  • 10龚俊扬,孙奋勇,罗其中.人脑胶质细胞瘤中血管内皮生长因子基因的表达研究[J].实用癌症杂志,2000,15(3):270-272. 被引量:5

二级参考文献37

  • 1左焕琮,王世杰,赵奎明,唐文渊,马廉亭.恶性胶质瘤同步放射化学治疗继以动脉灌注嘧啶亚硝脲治疗观察[J].中华神经外科杂志,1996,12(4):201-204. 被引量:20
  • 2刘敏芝,宋洪臣,黄民,魏俊杰,张红军.东亚钳蝎毒素的镇痛作用与吗啡镇痛作用的比较[J].白求恩医科大学学报,1995,21(3):260-262. 被引量:7
  • 3何钧珑,徐晓也,任雅明.蝎毒对大白鼠血浆中血栓烷B2、6-酮-前列腺素F1a的影响[J].苏州医学院学报,1995,15(1):35-36. 被引量:12
  • 4[2]Samoto K, Ikezaki K, Ono M et al .Expression of vas cular endothelial growth factor and its possible relation with neovascularization in human brain tumors.Cancer Res, 1995, 55:1189
  • 5[3]Plate KH, Breier G, Weich HA et al .Vascular endothelial growth factor and glioma angiogenesis: coordinate induction of VEGF receptors distribution of VEGF protein and possible in vivo regulatory mechanisms.Int J Cancer,1994,59:520
  • 6[4]Abdulraf SI,Edrardsen K,Ho KL et al .Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with lowgrade astrocytoma.J Neurosurg,1998,88(3):513
  • 7Todd D. Armstrong,Beth A. Pulaski,S. Ostrand-Rosenberg.Tumor antigen presentation: changing the rules[J]. Cancer Immunology, Immunotherapy . 1998 (2)
  • 8GalanisE,BucknerJ.Chemotherapy for high-grade gliomas. British Journal of Cancer . 2000
  • 9AlaviJB,EckSL.Gene therapy for malignant gliomas. HematolOncolClinNorthAm . 1998
  • 10LiauLM,BlackKL,PrinsRM,etal.Treatment of intracranial gliomas with bone marrow-derived dendritic cells pulsed with tumor antigens. Journal of Neurosurgery . 1999

共引文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部